State Street Corp. Updates Stake in Rhythm Pharmaceuticals
Ticker: RYTM · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1649904
| Field | Detail |
|---|---|
| Company | Rhythm Pharmaceuticals, Inc. (RYTM) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, beneficial-ownership
TL;DR
**State Street still holds Rhythm Pharma shares, signaling institutional interest.**
AI Summary
State Street Corporation, a major financial institution, filed an updated SC 13G/A on January 23, 2024, indicating its ownership in Rhythm Pharmaceuticals, Inc. as of December 31, 2023. This filing is an amendment, meaning State Street previously reported its stake. For investors, this matters because it shows a large institutional investor continues to hold a position in Rhythm Pharmaceuticals, suggesting ongoing confidence or a strategic investment, which can influence market perception.
Why It Matters
This filing confirms State Street Corporation's continued institutional ownership in Rhythm Pharmaceuticals, which can be seen as a vote of confidence from a major financial player.
Risk Assessment
Risk Level: low — This is a routine update from an institutional investor and does not indicate any immediate negative or positive financial risk.
Analyst Insight
An investor should note that a major institution like State Street Corporation maintains a position in Rhythm Pharmaceuticals, which could be a factor in their own investment thesis, but this filing alone doesn't provide enough detail to warrant immediate action.
Key Players & Entities
- State Street Corporation (company) — the reporting person filing the SC 13G/A
- Rhythm Pharmaceuticals, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating an update to previously reported beneficial ownership.
Who is the reporting person in this filing?
The reporting person is State Street Corporation, identified by CIK 0000093751.
Which company's securities are being reported on?
The securities being reported on belong to RHYTHM PHARMACEUTICALS, INC., identified by CIK 0001649904.
What is the CUSIP number for the securities mentioned?
The CUSIP number for the Common Stock of Rhythm Pharmaceuticals Inc. is 76243J105.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding RHYTHM PHARMACEUTICALS, INC. (RYTM).